Long-term Outcome
10
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
30%
3 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve Block
Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery
Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery
Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China
Long-term Outcome of Patients Treated With Extracorporeal Membrane Oxygenation
Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients
Epidural Anesthesia-analgesia and Long-term Outcome
Epidural Anesthesia and Long-term Outcomes in Elderly Patients After Surgery